Hongda Group has been awarded the title of National Intellectual Property Advantage Enterprise.
Release date:
2023-12-12
On December 6, the National Intellectual Property Administration released the list of newly designated National Intellectual Property Advantage Enterprises for 2023, and Jiangxi Hongda Medical Device Group Co., Ltd. was recognized as a National Intellectual Property Advantage Enterprise. This accolade underscores Hongda Group’s relentless efforts and outstanding innovation.
Leveraging its deep technological expertise and a steadfast commitment to innovation, Hongda Group has successfully developed a portfolio of medical devices with proprietary intellectual property, filling critical gaps in the domestic market. These high‑quality products have not only achieved strong performance in both domestic and international markets but have also made significant contributions to driving the transformation and upgrading of the healthcare industry.
Intellectual property serves as a robust safeguard for innovation and development, and it is also the core driving force behind Hongda Group’s sustained, healthy growth. Hongda Group has achieved remarkable results in the creation, utilization, protection, and management of intellectual property, fully demonstrating the strength and influence of a nationally recognized leading enterprise in this field.

→ Related News
0791-85628888
在线咨询